ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,287Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 316

$450K Total Retail Price of All Prescriptions

Rank: 31 out of 316

305 Patients Receiving at Least One Drug in Part D
92% Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Montana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

18% of this provider’s 305 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 305 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Montana
DONEPEZIL HCL 403 391 73 1 38
FUROSEMIDE 355 317 51 2 6
POTASSIUM CHLORIDE 340 323 57 3 9
MIRTAZAPINE 334 334 63 4 51
LEVOTHYROXINE SODIUM 325 266 52 5 1
SERTRALINE HCL 309 282 57 6 20
OMEPRAZOLE 291 244 61 7 5
NAMENDA 255 217 35 8 37
GABAPENTIN 227 177 35 9 16
ESCITALOPRAM OXALATE 217 212* 31 10 57
SIMVASTATIN 215 215 37 11 2
LISINOPRIL 172 139 37 12 3
QUETIAPINE FUMARATE 152 132 24 A 13 52
HYDROCODONE-ACETAMINOPHEN 151 146* 41 S3 14 4
CYMBALTA 151 125 16 14 27
WARFARIN SODIUM 150 145* 18 16 10
IPRATROPIUM-ALBUTEROL 137 132* 45 17 89
CITALOPRAM HBR 125 120* 25 18 17
TAMSULOSIN HCL 117 101 18 19 19
POLYETHYLENE GLYCOL 3350 114 109* 34 20 53
METOPROLOL TARTRATE 113 100 25 21 13
LORAZEPAM 112 107* 41 B 22 21
TRAMADOL HCL 104 99* 37 23 24
RANITIDINE HCL 93 88* 27 24 58
LYRICA 91 <11 <11 25 79
CLOPIDOGREL 84 84 14 26 33
FENTANYL 84 79* 20 S2 26 39
PREDNISONE 73 68* 15 28 40
RISPERIDONE 70 59 15 A 29 65
LANTUS SOLOSTAR 69 64* 13 30 69
AMLODIPINE BESYLATE 65 48 15 31 7
CARVEDILOL 64 <11 <11 32 26
ATORVASTATIN CALCIUM 63 <11 <11 33 12
METOPROLOL SUCCINATE 63 42 12 33 15
METOCLOPRAMIDE HCL 59 <11 <11 35 135
FLUTICASONE PROPIONATE 57 46 16 36 42
TRAZODONE HCL 56 <11 <11 37 32
ATENOLOL 56 <11 <11 37 18
FAMOTIDINE* 55 <11 <11 39 74
NOVOLOG FLEXPEN 52 38 15 40 122
OXYCODONE HCL 52 41 19 S2 40 34
CARBIDOPA-LEVODOPA 50 45* 11 42 111
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.